Originally Posted by
Maxtrade
Tend to agree with your comments Pierre. For that reason and minimal forward moving updates it is likely we still may see the share price erode further. The longer any real supporting data the higher the risk SP may sink further. We should not be surprised or disgruntled if we see a few sells over the next couple of weeks sending the SP sliding back into low to mid 0.8's again. it is entirely feasible in the current environment that this is a possibility with PEB. As you say not for the faint hearted investors.
Based off it's technicals, neg P/E, etc, the current SP is obviously indicative of investors relying on future revenue growth, lab test adoption, and faith in the company. The SP is speculative and difficult to value at this stage. Hence why with lack of news updates with a growth stocks such as PEB we see SP downtrends. Surprising to see SP hasn't settled back into the 0.8's again already but looks like trending that way for now.